Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04970433
Other study ID # NMRPG8L6041
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 12, 2021
Est. completion date July 2024

Study information

Verified date July 2021
Source Chang Gung Memorial Hospital
Contact Chun-Ting Liu, Dr.
Phone 0773171232334
Email juntin0214@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Major trauma is a significant cause for morbidity and mortality in the world. After traumatic injury, the damage tissue could induce systemic inflammatory response (SIRS) and activate autonomic nervous system in response to stress, followed by compensatory anti-inflammatory response (CARS). Imbalance of SIRS and CARS may lead to organ failures, sepsis and death.


Description:

The investigators design a prospective clinical trial to investigate the efficacy of acupuncture for major trauma.


Recruitment information / eligibility

Status Recruiting
Enrollment 180
Est. completion date July 2024
Est. primary completion date May 2024
Accepts healthy volunteers No
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria: - Male or female aged 20 years or older - Confirmed diagnosis of major trauma with ISS = 16 Exclusion Criteria: - Pregnancy - Malignancy - Pacemaker - Status epilepticus - Severe medical disease - Life threatening - Prior history of drug or alcohol dependence - Immunodeficiency - Vagotomy

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Electroacupuncture (EA)
Acupuncture at Hegu (LI4), Neiguan (PC6), Zusanli (ST36), Sanyinjiao (SP6) and Sishencong (EX-HN1). Electrical stimulation with a pair of electrodes connecting on LI4/PC6 and ST36/SP6.
Laser acupuncture (LA)
The laser applies to each point for 40 seconds, which delivers 3 J of energy at each of the acupoints as those in electroacupuncture group.
Sham laser acupuncture (SLA)
The laser device without any laser output applies on the acupoints the same as those in the LA group.

Locations

Country Name City State
Taiwan Kaohsiung Chang Gung Memorial Hospital Kaohsiung

Sponsors (1)

Lead Sponsor Collaborator
Chang Gung Memorial Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Length of hospital stay Count the total days of hospitalization up to 24 weeks
Secondary CRP Inflammatory mediator, CRP measured at 48 hours, 7 days and 14 days
Secondary IL-6 Inflammatory mediator, IL-6 measured at 48 hours, 7 days and 14 days
Secondary TNF-a Inflammatory mediator, TNF-a measured at 48 hours, 7 days and 14 days
Secondary IL-1ß Inflammatory mediator, IL-1ß measured at 48 hours, 7 days and 14 days
Secondary IL-10 Inflammatory mediator, IL-10 measured at 48 hours, 7 days and 14 days
Secondary Sequential organ failure assessment (SOFA) score The SOFA score is a simple and objective score that allows for calculation of both the number and the severity of organ dysfunction in six organ systems (respiratory, coagulatory, liver, cardiovascular, renal, and neurologic), and the score can measure individual or aggregate organ dysfunction.The SOFA score ranges from 0 to 24; higher scores mean a worse outcome. measured at 48 hours, 7 days and 14 days
Secondary WHO Disability Assessment Schedule 2.0 (WHODAS 2.0) 12-item version WHODAS 2.0 is used to measure of disability after major trauma. measured at 3 and 6 months
Secondary Peripheral Blood Mononuclear Cell (PBMC) analysis PBMC analysis by flow cytometry measured at 48 hours, 7 days and 14 days
See also
  Status Clinical Trial Phase
Recruiting NCT02509390 - Hyperfibrinogenemia After Major Trauma N/A
Recruiting NCT04588311 - ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients Phase 3
Active, not recruiting NCT04144803 - Brain Oxygenation During Prehospital Anesthesia: an Observational Study
Completed NCT03259776 - Experiences of Visitors to a Regional Major Trauma Intensive Care Unit
Recruiting NCT05449522 - Vitamin D for Critically Traumatic Patients N/A
Not yet recruiting NCT06103292 - Calcium Levels in Major Trauma
Recruiting NCT02877342 - Pre-hospital Notification of Injured Patients Presenting to Trauma Centres in India N/A
Terminated NCT01545635 - RETIC Trial: Reversal of Trauma Induced Coagulopathy Using Coagulation Factor Concentrates or Fresh Frozen Plasma Phase 3
Completed NCT03986736 - Markers of Tissue Injury and Rhabdomyolysis in Patients With Major Trauma
Completed NCT03005509 - Structured Trauma Quality Improvement Meetings at Four Trauma Centres in India N/A
Completed NCT02165137 - Management of Major Trauma Patients at Aarau Trauma Center - Evaluation of Processes and Patient Outcome
Active, not recruiting NCT06376318 - Shock and Acute Conditions OutcOmes Platform
Recruiting NCT05996068 - Arterial Line in Trauma Resuscitation N/A
Completed NCT06007807 - Severe Trauma Registry in Tarragona
Completed NCT03354559 - Trauma Associated Bleeding: Effectiveness of an Early Coagulation Support Protocol N/A
Recruiting NCT05652790 - Enhanced Rehabilitation After Major Trauma (PROPERLY) N/A
Completed NCT00588796 - Study of Fibrinogen Metabolism During Severe Trauma and Burns N/A
Completed NCT04216459 - Effect of Anti-inflammatory and Anti-microbial Co-supplementations in Traumatic ICU Patients at High Risk of Sepsis N/A
Terminated NCT04551157 - Impact of Psychoeducational Video on Adjustment to Open Fracture. N/A
Completed NCT02000674 - Succinylcholine vs Rocuronium for Prehospital Emergency Intubation Phase 3